PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
10-Dec-2024 Resolution Therapeutics Announces Presentation at Keystone Symposia on Fibrosis Resolution Therapeutics
10-Dec-2024 Trading update for year ending 31 December 2024 and an early outlook for 2025 Cambridge Cognition Holdings plc
10-Dec-2024 Santhera Receives Positive Recommendation from NICE for AGAMREE® (Vamorolone) as a Treatment for Duchenne Muscular Dystrophy Santhera
10-Dec-2024 Ichnos Glenmark Innovation (IGI) Presents First Clinical Data from Phase 1 Study of Trispecific TREAT™ Antibody, ISB 2001, Showing High Overall Response Rate (ORR) with Durable Responses and Favorable Safety Profile in Patients with Heavily Pretreated Multiple Myeloma Ichnos Glenmark Innovation (IGI)
10-Dec-2024 Kite’s Yescarta® Only CAR T-Cell Therapy to Show Durable Response and Long-Term Survival After Five Years in Patients With Relapsed/Refractory Non-Hodgkin Lymphomas at ASH 2024 Kite
10-Dec-2024 ASH: Sarclisa combinations demonstrated significant benefits in newly diagnosed multiple myeloma patients Sanofi
10-Dec-2024 ELLIPSES PHARMA PUBLISHES DATA FROM ONGOING PHASE 1/2 CLINICAL TRIAL OF EP0042 ELLIPSES PHARMA
10-Dec-2024 Germfree Launches Smarthood™: A Groundbreaking, Software-Agnostic IV Workflow Solution Transforming Sterile Compounding Germfree
09-Dec-2024 HONEYWELL INTRODUCES LIQUID FLOW SENSING SOLUTION TO IMPROVE MEDICATION DELIVERY FOR PATIENTS AND CLINICIANS HONEYWELL
09-Dec-2024 Ingenious partners with Unfound Studio to redefine brand identity Ingenious
09-Dec-2024 Poolbeg Pharma plc presents POLB 001 pre-clinical study data at the 66th American Society of Hematology (ASH) Annual Meeting Poolbeg Pharma plc
09-Dec-2024 DARZALEX® (daratumumab) SC-based regimens improve MRD negativity and progression-free survival in newly diagnosed multiple myeloma, and overall survival in AL amyloidosis Janssen-Cilag International NV
09-Dec-2024 PureTech Presents Data for LYT-200 (anti-galectin-9 monoclonal antibody) for Relapsed/Refractory AML/MDS at the 2024 ASH Annual Meeting PureTech
09-Dec-2024 Kester Capital backs experienced management team in acquiring EMAS Pharma Kester Capital
09-Dec-2024 Bionical Emas sells EMAS Pharma to Kester Capital following strategic review Bionical Emas
09-Dec-2024 TECVAYLI®▼ (teclistamab) demonstrates potential as frontline combination therapy for patients with newly diagnosed multiple myeloma Janssen-Cilag International NV
09-Dec-2024 aap informs about the invitation to the Annual General Meeting on January 15, 2025 aap Implantate AG
09-Dec-2024 MS Pharma becomes Partner for the Commercialization of FYB202 / ustekinumab in the MENA Region Formycon AG
06-Dec-2024 Her Royal Highness The Princess Royal Visits Crane Company’s New Saunders Valves Manufacturing Facility In Cwmbran, South Wales, To Celebrate Industrial Innovation And Charitable Commitment Crane Company
06-Dec-2024 Vapourtec unveils Peptide-Builder Vapourtec